Fairvalue-Calculator Fairvalue-Calculator
EN DE

Genetics Generation Advancement Corp (4160) Fair Value & Analysis

Healthcare · TW · Market cap 1.1B TWD

Price39.30 TWD
Fair Value16.01 TWD
Upside-59.3%
Quality95/100
Evidence: High Range 12.01 TWD – 20.02 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Genetics Generation Advancement Corp (4160) currently trades at 39.30 TWD, while our model-based Fair Value estimate is 16.01 TWD — implying the stock looks roughly 59.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and development management, enterprise quality management, process production operation, and e-submission products. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -34% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -54% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -50%

Frequently asked questions

Is Genetics Generation Advancement Corp (4160) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 16.01 TWD versus a price of 39.30 TWD — about −59% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 4160?
Our 21-model fair value for Genetics Generation Advancement Corp is 16.01 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 39.30 TWD.
What is the quality score of 4160?
Genetics Generation Advancement Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.